Applied Biology COVID-19 Anti-Androgen Patent Considered for Special COVID-19 Prioritized Examination in the United States Patent and Trademark Office

IRVINE, Calif.--(BUSINESS WIRE)-- #COVID19--While studying the effects of androgens on hair loss, Applied Biology scientists discovered an association between baldness (androgenetic alopecia) and the risk of COVID-19 disease severity. This discovery prompted the company to seek patent protection for technology related to systems, methods and kits for diagnostics and treatment of SARS-CoV-2. “This is a very exciting finding in which the expression of the enzyme [TMPRSS2] implicated in SARS-CoV-2 viral infe

Click to view original post